CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Nicotine patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03873337
NCT03873337N/ACompleted
CompareCT.gov

Persistence Targeted Smoking Cessation in Schizophrenia (PTSC-S)

Rutgers, The State University of New Jersey·interventional·Posted Mar 13, 2019·Updated Sep 13, 2022

In Brief

A clinical study evaluating Persistence Targeted Smoking Cessation in SMI (PTSC-S) and Nicotine patch for Tobacco Use and 5 related conditions. Completed, enrolled 34 participants across 1 site.

Detailed Summary

Due to the pandemic, this study was modified from a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention to a feasibility and acceptability test of our intervention when delivered via telehealth in a single group, within-subjects design.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use, Tobacco Smoking, Tobacco Use Cessation, Tobacco Use Disorder, Schizophrenia, Schizoaffective Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 13, 2019
Enrollment StartApr 22, 2019
Primary CompletionJan 10, 2022
Study CompletionJan 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 7.3 years ago

Interventions

Persistence Targeted Smoking Cessation in SMI (PTSC-S)behavioral

All participants will receive 8 weeks of persistence focused smoking cessation counseling delivered via telehealth

Nicotine patchdrug

All participants will receive 10 weeks of nicotine patch